Biotron Limited Stock: price and insider trades · Australia
Biotron Limited: what insiders have been doing
Biotron Limited is a Health Care company. Its directors and officers file their transactions with ASX. 5 insiders have disclosed 5 filings since 19 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Compared with its exchange (1,605 companies, median 4 filings), a count of 5 filings is above the norm.
Insider buying of Biotron Limited has been absent for the past year.
Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Financial data
as of FY 2024FY ended June 2024 · cache
- ShareASXISIN AU000000BIT4ASX:2924-03149715-2A1704703
- ShareASXISIN AU000000BIT4ASX:2924-03135092-2A1696918
- ShareASXISIN AU000000BIT4ASX:2924-03122352-2A1690152
- 12,152,433 sharesShareASXASX:2924-03111350-2A1684608
- ShareASXISIN AU000000BIT4ASX:2924-03090484-2A1672245
5 of 5 declarations
About Biotron Limited
Biotron Limited is an Australian biopharmaceutical company focused on developing treatments for viral diseases and immune disorders. It is listed on the Australian Securities Exchange (XASX).
